![Catherine Marle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Catherine Marle held the position of Head-Clinical Operations at AB Science SA from 2015 to 2019 and later served as Chief Operating Officer at Enterome SA from 2019 to 2022.
Former positions of Catherine Marle
| Companies | Position | End |
|---|---|---|
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Chief Operating Officer | 2022-06-30 |
| AB SCIENCE | Chief Tech/Sci/R&D Officer | 2018-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
AB Science SA
 AB Science SA Pharmaceuticals: OtherHealth Technology Provides biochemical research services | Health Technology |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Catherine Marle
Choose MarketScreener 
